Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
EDQM
0
USP
0
JP
0
Others
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
API
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
Regulatory Info :
Registration Country : Switzerland
Brand Name : Ocrevus
Dosage Form : Inf Conc
Dosage Strength : 300mg/10ml
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Switzerland
Regulatory Info : Prescription
Registration Country : Canada
Brand Name : OCREVUS
Dosage Form : SOLUTION
Dosage Strength : 30MG/ML
Packaging : 15ML VIAL
Approval Date :
Application Number : 2467224
Regulatory Info : Prescription
Registration Country : Canada
Regulatory Info : Originator
Registration Country : South Africa
Brand Name : Ocrevus
Dosage Form : INF
Dosage Strength : 300mg
Packaging : 10X1mg
Approval Date :
Application Number :
Regulatory Info : Originator
Registration Country : South Africa
Regulatory Info :
Registration Country : Australia
Brand Name : Ocrevus
Dosage Form :
Dosage Strength :
Packaging : 1
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Australia
Regulatory Info :
Registration Country : Australia
Brand Name : Ocrevus
Dosage Form :
Dosage Strength :
Packaging : 1
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Australia
Regulatory Info :
Registration Country : USA
Brand Name : OCREVUS
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 30MG/1ML
Packaging :
Approval Date :
Application Number : 761053
Regulatory Info :
Registration Country : USA
Global Sales Information
Market Place
Reply
28 Dec 2020
ABOUT THIS PAGE